Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia
暂无分享,去创建一个
K. Parmar | P. Mauch | J. Vergilio | J. Down | R. Sackstein
[1] Crispin J. Miller,et al. Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. , 2006, Blood.
[2] Brian Keith,et al. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. , 2006, Genes & development.
[3] F. Camargo,et al. Hematopoietic stem cells do not engraft with absolute efficiencies. , 2006, Blood.
[4] U. Lendahl,et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.
[5] B. Williams,et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. , 2005, Blood.
[6] S. Morrison,et al. Supplemental Experimental Procedures , 2022 .
[7] Xunbin Wei,et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment , 2005, Nature.
[8] Y. Ko,et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size , 2005, The Journal of experimental medicine.
[9] J. Bussink,et al. Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters. , 2004, International journal of radiation oncology, biology, physics.
[10] Geoffrey C Gurtner,et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.
[11] Keisuke Ito,et al. Tie2/Angiopoietin-1 Signaling Regulates Hematopoietic Stem Cell Quiescence in the Bone Marrow Niche , 2004, Cell.
[12] J. Shay,et al. Hypoxia-Inducible Factor 1 Mediates Upregulation of Telomerase (hTERT) , 2004, Molecular and Cellular Biology.
[13] J. Brown,et al. Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.
[14] S. Kyo,et al. HIF-1-mediated activation of telomerase in cervical cancer cells , 2004, Oncogene.
[15] J. Schuetz,et al. The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.
[16] D. Bonnet,et al. Multiparameter analysis of murine bone marrow side population cells. , 2004, Blood.
[17] D. Scadden,et al. Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.
[18] Haiyang Huang,et al. Identification of the haematopoietic stem cell niche and control of the niche size , 2003, Nature.
[19] M. Simon,et al. Expansion of human SCID-repopulating cells under hypoxic conditions. , 2003, The Journal of clinical investigation.
[20] Maris Handley,et al. Sca+CD34- murine side population cells are highly enriched for primitive stem cells. , 2003, Experimental hematology.
[21] W. Bloomer,et al. Therapeutic advantage from combining 5-fluorouracil with the hypoxia-selective cytotoxin NLCQ-1 in vivo; comparison with tirapazamine , 2002, Cancer Chemotherapy and Pharmacology.
[22] M. Dewhirst,et al. Hypoxia in the thymus: role of oxygen tension in thymocyte survival. , 2002, American journal of physiology. Heart and circulatory physiology.
[23] P. Olive,et al. Local hypoxia is produced at sites of intratumour injection , 2002, British Journal of Cancer.
[24] H. Nakauchi,et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype , 2001, Nature Medicine.
[25] W M Miller,et al. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. , 2001, Biophysical journal.
[26] S. Nilsson,et al. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. , 2001, Blood.
[27] D. Hirst,et al. The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N , 2001, British Journal of Cancer.
[28] V. Praloran,et al. Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent , 2000, Transfusion.
[29] C. Aquino-Parsons,et al. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia , 2000, British Journal of Cancer.
[30] P. Wesseling,et al. Hypoxia in a human intracerebral glioma model. , 2000, Journal of neurosurgery.
[31] R. Johnson,et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species , 1997, Nature Medicine.
[32] A. S. Conner,et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.
[33] H. Thames,et al. Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation. , 1995, Blood.
[34] M. Olivotto,et al. The role of hypoxia in the maintenance of hematopoietic stem cells. , 1993, Blood.
[35] J. Down,et al. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. , 1993, Experimental hematology.
[36] C. Coleman,et al. Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma. , 1992, Journal of the National Cancer Institute.
[37] M. Baert,et al. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. , 1991, Blood.
[38] Der,et al. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. , 1989, Blood.
[39] H. Kumar,et al. An experiment in involvement of teachers in family welfare programme. , 1978, POPCEN news letter. Population Centre.
[40] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[41] A. Grimminger. [Changes of the bronchial structure in sarcoidosis (course and bronchoscopic picture of the disease)]. , 1955, Der Tuberkulosearzt.
[42] H. Okano,et al. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. , 2004, Immunity.
[43] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.
[44] I. Weissman,et al. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. , 2001, Annual review of cell and developmental biology.
[45] Raleigh,et al. Measuring Tumor Hypoxia. , 1996, Seminars in radiation oncology.
[46] B. Lord. The architecture of bone marrow cell populations. , 1990, International journal of cell cloning.
[47] D. Chaplin,et al. Cell sorting with Hoechst or carbocyanine dyes as perfusion probes in spheroids and tumors. , 1990, Methods in cell biology.
[48] R. Schofield. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. , 1978, Blood cells.